Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys
- 1.7k Downloads
Dopaminergic neurotransmission is critically involved in many aspects of complex behavior and cognition beyond reward/reinforcement and motor function. Mental and behavioral disorders associated with major disruptions of dopamine neurotransmission, including schizophrenia, attention deficit/hyperactivity disorder, Parkinson’s disease, Huntington’s disease, and substance abuse produce constellations of neuropsychological deficits in learning, memory, and attention in addition to other defining symptoms.
To delineate the role dopaminergic D1- and D2-like receptor subtypes play in complex brain functions.
Materials and methods
Monkeys (N=6) were trained on cognitive tests adapted from a human neuropsychological assessment battery (CAmbridge Neuropsychological Test Automated Battery). The battery included tests of spatial working memory (self-ordered spatial search task), visuo-spatial associative memory and learning (visuo-spatial paired associates learning task, vsPAL) and motivation (progressive ratio task, PR). Tests of motor function (bimanual motor skill task, BMS; rotating turntable task, RTT) were also included. The effects of the dopamine D2-like antagonist raclopride (10–56 μg/kg, i.m.) and the D1-like antagonist SCH23390 (SCH, 3.2–56 μg/kg, i.m.) on cognitive performance were then determined.
Deficits on PR, RTT, and BMS performance were observed after both raclopride and SCH23390. Spatial working memory accuracy was reduced to a greater extent by raclopride than by SCH, which was unexpected, given prior reports on the involvement of D1 signaling for spatial working memory in monkeys. Deficits were observed on vsPAL performance after raclopride, but not after SCH23390.
The intriguing results suggest a greater contribution of D2- over D1-like receptors to both spatial working memory and object–location associative memory.
KeywordsAlzheimer’s disease Parkinson’s disease Substance abuse Working memory ADHD Motor function Aging
This work was supported by USPHS grants DA13390 and MH61692. This is publication #16573-NP from The Scripps Research Institute.
- Aalto S, Bruck A, Laine M, Nagren K, Rinne JO (2005) Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci 25:2471–2477PubMedCrossRefGoogle Scholar
- Duchesne N, Soucy JP, Masson H, Chouinard S, Bedard MA (2002) Cognitive deficits and striatal dopaminergic denervation in Parkinson’s disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa. Clin Neuropharmacol 25:216–224PubMedCrossRefGoogle Scholar
- Katner SN, Davis SA, Kirsten AJ, Taffe MA (2004a) Effects of nicotine and mecamylamine on cognition in rhesus monkeys. Psychopharmacology (Berl) 175:225–240Google Scholar
- Taffe MA, Bernot TJ, Mckay HL, Davis SA, Roberts JA, Tuszynski MH (2003a) Adaptation of a computerized neuropsychological testing battery to the aged macaque. Society for Neuroscience annual meeting, New Orleans, LAGoogle Scholar
- Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001a) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatr 158:2015–2021PubMedCrossRefGoogle Scholar
- Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001b) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatr 158:377–382PubMedCrossRefGoogle Scholar